Key features and details
- Chicken polyclonal to Carcino Embryonic Antigen CEA
- Suitable for: ELISA
- Reacts with: Human
- Isotype: IgY
Product nameAnti-Carcino Embryonic Antigen CEA antibody
See all Carcino Embryonic Antigen CEA primary antibodies
DescriptionChicken polyclonal to Carcino Embryonic Antigen CEA
Specificityab30913 recognises Carcinoembryonic Antigen (CEA, CD66e)
Tested applicationsSuitable for: ELISAmore details
Species reactivityReacts with: Human
Human carcinoembryonic antigen (CEA)
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Add glycerol to a final volume of 50% for extra stability and aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Storage bufferpH: 7.40
Preservative: 0.01% Sodium azide
Constituent: Tris buffered saline
Concentration information loading...
Purification notesPurified by solvent extraction and column chromatography.
Our Abpromise guarantee covers the use of ab30913 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent dilution.|
FunctionCell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins.
Tissue specificityFound in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon.
Sequence similaritiesBelongs to the immunoglobulin superfamily. CEA family.
Contains 7 Ig-like (immunoglobulin-like) domains.
modificationsComplex immunoreactive glycoprotein with a MW of 180 kDa comprising 60% carbohydrate.
Cellular localizationCell membrane.
- Information by UniProt
- Carcinoembryonic antigen antibody
- Carcinoembryonic antigen-related cell adhesion molecule 5 antibody
- CD66e antibody
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab30913 has been referenced in 1 publication.
- Huo Q Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay. Colloids Surf B Biointerfaces 78:259-65 (2010). PubMed: 20392611